Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Keratoconjunctivitis

• Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearers
• Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye
• Study of INV-102 Ophthalmic Solution in Adults With Acute Infectious Keratoconjunctivitis
• Safety, Tolerability and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort B
• Cyclosporine 0.05% Eye Drops for Vernal Keratoconjunctivitis Trial
• Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream (4%, 6%, 8%)
• Treatment of Dry Eye Disease Using Pro-ocular™ - A Proof of Concept, Safety, and Efficacy Study
• Topical Immuonosuppressant Drugs in Spring Catarrh
• Mesenchymal Stem Cell Therapy of Dry Eye Disease in Patients With Sjögren's Syndrome
• Topical Steroids and Cyclosporin-A for COVID-19 Keratoconjunctivitis
• A Randomized Study of Smile Exercise for Dry Eye
• Treatment of Corneal Infiltrates Secondary to Epidemic Keratoconjunctivitis
• Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)
• Modified Treatment for Epidemic Keratoconjunctivitis (EKC)
• Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution in Subjects With Dry Eye Syndrome
• Povidone-iodine 2% Eye Drop Versus Artificial Tear Drop for Treatment of Adenoviral Keratoconjunctivitis
• Topical rVA576 for Treatment of Atopic Keratoconjunctivitis
• Levocarnitine for Dry Eye in Sjogren's Syndrome
• Tavilermide Ophthalmic Solution for the Treatment of Dry Eye
• Treatment With Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Aqueous Deficient Dry Eye Disease
• A Phase I Study of PP-001 Eye Drops in Healthy Adult Volunteers
• Safety and Efficacy of KPI-121 in Subjects With DED
• A Novel Combined Therapy for Refractory Vernal Keratoconjunctivitis
• Efficacy of Two Concentrations of Autologous Serum for the Treatment of Severe Dry Eye
• Effects of Xiidra on Closed Eye Tear Film Leukocytes in Dry Eye Disease
• Repository Corticotropin Injection in Keratoconjunctivitis Sicca
• A Study of AK002 in Patients With Atopic Keratoconjunctivitis, Vernal Keratoconjunctivitis, and Perennial Allergic Conjunctivitis
• An Open-Label Extension of a Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca
• Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
• Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
• Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca
• A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye Disease
• A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye
• Topical Tacrolimus in Vernal Keratoconjunctivitis
• Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca
• Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
• A Phase 4 Study Investigating the Efficacy of Retaine™ in Managing Signs and Symptoms Associated With Dry Eye Syndrome
• A Clinical Study to Assess the Safety and Efficacy of an Ophthalmic Solution (SkQ1) in the Treatment of Dry Eye Syndrome (DES)
• A Safety and Efficacy Study of OPTIVE FUSION™ With VISMED® Multi for the Management of Dry Eye
• Efficacy and Safety of Fluorometholone (FML) in Dry Eye Disease (Keratoconjunctivitis Sicca)
• Safety and Efficacy Study of R932348 Ophthalmic Solution in Chronic Ocular Graft Versus Host Disease Patients(DROPS-2)
• Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC)
• To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
• Lotemax® Gel 0.5% and Restasis 0.05% in Participants With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease)
• Effects of Dry Eye Treatments on the Ocular Surface
• Double-Masked Trial of NOVA22007 (1mg/mL Ciclosporin/Cyclosporine) Versus Vehicle in Pediatric Patients With Active Severe Vernal Keratoconjunctivitis
• A Safety, Tolerability and Pharmacokinetics Study of R932348 Eye Drops in Patients With Dry Eye Disease
• A Placebo Controlled Comparison of Topical Zirgan Versus Genteal Gel for the Treatment of Adenovirus Conjunctivitis
• Safety and Efficacy Study of SAR 1118 to Treat Dry Eye Conducted in a Controlled Adverse Environment (CAE) (OPUS-1)
• Trial of CF101 to Treat Patients With Dry Eye Disease
• A Study Of Tasocitinib In Dry Eye Subjects
• Topical Cyclosporine for Vernal Keratoconjunctivitis (VKC) in Rwanda
• Treatment of Epidemic Keratoconjunctivitis With 2% Povidone-iodine
• Efficacy and Safety of GV 550 in Acute Adenovirus Keratoconjunctivitis
• Dry Eye Assessment and Management: Feasibility Study
• Efficacy Study of FK-506 and Cyclosporine in Vernal Keratoconjunctivits (VKC)
• Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Subjects With Dry Eye - Effects on Central Cornea
• Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Patients With Dry Eye
• Safety and Efficacy of Carboxymethylcellulose for Ocular Surface Integrity in Symptomatic Dry Eye
• Long-term Topical Cyclosporine for Atopic Keratoconjunctivitis
• Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic Keratoconjunctivitis
• A Dose-Escalation Study to Assess the Safety and Tolerability of LX214 Ophthalmic Solution in Healthy Volunteers, Followed by an Open-Label Evaluation of LX214 in Patients With Keratoconjunctivitis Sicca (KCS)
• Efficacy and Safety Study of ATs in Patients With Dry Eye Syndrome
• Efficacy Study of Cyclosporine Ophthalmic Emulsion in Patients With Dry Eye Disease
• Tear Film Break-up Time After Instillation of Artificial Tears
• Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis
• Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis
• Lactobacillus Rhamnosus GG Oral Treatment Efficacy on Vernal Keratoconjunctivitis Treatment
• Effect of B-cell Depletion in Patients With Primary Sjögren's Syndrome
• Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis
• Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis
• Study of the Clinical and Biological Efficacity of NAAXIA SINE® in Vernal Keratoconjunctivitis
• Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca
• Effects of Systane Versus Saline in Maintaining Tear Film Stability at Determined Time Points
• Efficacy and Tolerance of Nova22007 Versus Vehicle in Patients With Vernal Keratoconjunctivitis (VKC)
• Study of Rebamipide Eye Drops to Treat Dry Eye
• Study of Rebamipide Eye Drops to Treat Dry Eye
• Safety and Efficacy of Pimecrolimus Ophthalmic Suspension in Patients With Moderate to Severe Keratoconjunctivitis Sicca
• Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye
• Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome
• Treatment of Dry Eye Syndrome With Cyclosporin A Eye Drops